ATE182073T1 - Ein brausesystem und einen arzneiwirkstoff enthaltendes granuläres produkt bzw. tablette sowie verfahren zu deren herstellung - Google Patents

Ein brausesystem und einen arzneiwirkstoff enthaltendes granuläres produkt bzw. tablette sowie verfahren zu deren herstellung

Info

Publication number: ATE182073T1
Authority: AT; Austria
Prior art keywords: acid; granular product; grains; pharmaceutically active; water
Prior art date: 1994-03-01

Application number

AT94203112T

Other languages

English (en)

Inventor

Gerhard Gergely

Thomas Gergely

Irmgard Gergely

Stefan Gergely

Original Assignee

Gerhard Gergely

Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)

1994-03-01

Filing date

1994-10-26

Publication date

1999-07-15

1994-10-26 Application filed by Gerhard Gergely filed Critical Gerhard Gergely

1999-07-15 Application granted granted Critical

1999-07-15 Publication of ATE182073T1 publication Critical patent/ATE182073T1/de

Links

239000002253 acid Substances 0.000 abstract 3
KRKNYBCHXYNGOX-UHFFFAOYSA-N citric acid Chemical compound OC(=O)CC(O)(C(O)=O)CC(O)=O KRKNYBCHXYNGOX-UHFFFAOYSA-N 0.000 abstract 3
239000013543 active substance Substances 0.000 abstract 2
BVKZGUZCCUSVTD-UHFFFAOYSA-M Bicarbonate Chemical compound OC([O-])=O BVKZGUZCCUSVTD-UHFFFAOYSA-M 0.000 abstract 1
VTYYLEPIZMXCLO-UHFFFAOYSA-L Calcium carbonate Chemical class [Ca+2].[O-]C([O-])=O VTYYLEPIZMXCLO-UHFFFAOYSA-L 0.000 abstract 1
BVKZGUZCCUSVTD-UHFFFAOYSA-L Carbonate Chemical compound [O-]C([O-])=O BVKZGUZCCUSVTD-UHFFFAOYSA-L 0.000 abstract 1
LFQSCWFLJHTTHZ-UHFFFAOYSA-N Ethanol Chemical compound CCO LFQSCWFLJHTTHZ-UHFFFAOYSA-N 0.000 abstract 1
239000003513 alkali Substances 0.000 abstract 1
OENHQHLEOONYIE-UKMVMLAPSA-N all-trans beta-carotene Natural products CC=1CCCC(C)(C)C=1/C=C/C(/C)=C/C=C/C(/C)=C/C=C/C=C(C)C=CC=C(C)C=CC1=C(C)CCCC1(C)C OENHQHLEOONYIE-UKMVMLAPSA-N 0.000 abstract 1
229940069428 antacid Drugs 0.000 abstract 1
239000003159 antacid agent Substances 0.000 abstract 1
230000001458 anti-acid effect Effects 0.000 abstract 1
TUPZEYHYWIEDIH-WAIFQNFQSA-N beta-carotene Natural products CC(=C/C=C/C=C(C)/C=C/C=C(C)/C=C/C1=C(C)CCCC1(C)C)C=CC=C(/C)C=CC2=CCCCC2(C)C TUPZEYHYWIEDIH-WAIFQNFQSA-N 0.000 abstract 1
235000013734 beta-carotene Nutrition 0.000 abstract 1
239000011648 beta-carotene Substances 0.000 abstract 1
229960002747 betacarotene Drugs 0.000 abstract 1
150000001720 carbohydrates Chemical class 0.000 abstract 1
229960001380 cimetidine Drugs 0.000 abstract 1
CCGSUNCLSOWKJO-UHFFFAOYSA-N cimetidine Chemical compound N#CNC(=N/C)\NCCSCC1=NC=N[C]1C CCGSUNCLSOWKJO-UHFFFAOYSA-N 0.000 abstract 1
DCSUBABJRXZOMT-IRLDBZIGSA-N cisapride Chemical compound C([C@@H]([C@@H](CC1)NC(=O)C=2C(=CC(N)=C(Cl)C=2)OC)OC)N1CCCOC1=CC=C(F)C=C1 DCSUBABJRXZOMT-IRLDBZIGSA-N 0.000 abstract 1
229960005132 cisapride Drugs 0.000 abstract 1
DCSUBABJRXZOMT-UHFFFAOYSA-N cisapride Natural products C1CC(NC(=O)C=2C(=CC(N)=C(Cl)C=2)OC)C(OC)CN1CCCOC1=CC=C(F)C=C1 DCSUBABJRXZOMT-UHFFFAOYSA-N 0.000 abstract 1
239000011248 coating agent Substances 0.000 abstract 1
238000000576 coating method Methods 0.000 abstract 1
239000013078 crystal Substances 0.000 abstract 1
-1 for example Substances 0.000 abstract 1
239000000416 hydrocolloid Substances 0.000 abstract 1
230000008018 melting Effects 0.000 abstract 1
238000002844 melting Methods 0.000 abstract 1
230000007935 neutral effect Effects 0.000 abstract 1
150000007524 organic acids Chemical class 0.000 abstract 1
VMXUWOKSQNHOCA-LCYFTJDESA-N ranitidine Chemical compound [O-][N+](=O)/C=C(/NC)NCCSCC1=CC=C(CN(C)C)O1 VMXUWOKSQNHOCA-LCYFTJDESA-N 0.000 abstract 1
229960000620 ranitidine Drugs 0.000 abstract 1
239000007787 solid Substances 0.000 abstract 1
239000000126 substance Substances 0.000 abstract 1
229920003169 water-soluble polymer Polymers 0.000 abstract 1
OENHQHLEOONYIE-JLTXGRSLSA-N β-Carotene Chemical compound CC=1CCCC(C)(C)C=1\C=C\C(\C)=C\C=C\C(\C)=C\C=C\C=C(/C)\C=C\C=C(/C)\C=C\C1=C(C)CCCC1(C)C OENHQHLEOONYIE-JLTXGRSLSA-N 0.000 abstract 1

Classifications

- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/0002—Galenical forms characterised by the drug release technique; Application systems commanded by energy
- A61K9/0007—Effervescent

Landscapes

Health & Medical Sciences (AREA)
Epidemiology (AREA)
Animal Behavior & Ethology (AREA)
Chemical & Material Sciences (AREA)
Medicinal Chemistry (AREA)
Pharmacology & Pharmacy (AREA)
Engineering & Computer Science (AREA)
Life Sciences & Earth Sciences (AREA)
Bioinformatics & Cheminformatics (AREA)
General Health & Medical Sciences (AREA)
Public Health (AREA)
Veterinary Medicine (AREA)
Medicinal Preparation (AREA)
Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)

AT94203112T 1994-03-01 1994-10-26 Ein brausesystem und einen arzneiwirkstoff enthaltendes granuläres produkt bzw. tablette sowie verfahren zu deren herstellung ATE182073T1 (de)

Applications Claiming Priority (2)

Application Number	Priority Date	Filing Date	Title
DE4406641		1994-03-01
CH87394		1994-03-23

Publications (1)

Publication Number	Publication Date
ATE182073T1 true ATE182073T1 (de)	1999-07-15

Family

ID=25685969

Family Applications (1)

Application Number	Title	Priority Date	Filing Date
AT94203112T ATE182073T1 (de)	1994-03-01	1994-10-26	Ein brausesystem und einen arzneiwirkstoff enthaltendes granuläres produkt bzw. tablette sowie verfahren zu deren herstellung

Country Status (6)

Country	Link
EP (1)	EP0670160B1 (de)
KR (1)	KR100358211B1 (de)
AT (1)	ATE182073T1 (de)
DE (1)	DE69419492T2 (de)
DK (1)	DK0670160T3 (de)
ES (1)	ES2136157T3 (de)

Families Citing this family (31)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
US5824339A (en) *	1995-09-08	1998-10-20	Takeda Chemical Industries, Ltd	Effervescent composition and its production
US6489346B1 (en) *	1996-01-04	2002-12-03	The Curators Of The University Of Missouri	Substituted benzimidazole dosage forms and method of using same
US5840737A (en)	1996-01-04	1998-11-24	The Curators Of The University Of Missouri	Omeprazole solution and method for using same
DE69713948D1 (de) *	1996-04-23	2002-08-22	Janssen Pharmaceutica Nv	Rasch-freisetzende pH-unabhängige feste Dosisformen enthaltend Cisaprid
EP0803251B1 (de) *	1996-04-23	2002-07-17	Janssen Pharmaceutica N.V.	Rasch-freisetzende pH-unabhängige feste Dosisformen enthaltend Cisaprid
US20030087005A1 (en)	1996-10-10	2003-05-08	Peter Baron	Drink flavouring straw
AUPS270602A0 (en)	2002-05-31	2002-06-20	Baron, Peter	Drink flavouring straw
US5807580A (en) *	1996-10-30	1998-09-15	Mcneil-Ppc, Inc.	Film coated tablet compositions having enhanced disintegration characteristics
FR2758265B1 (fr) *	1997-01-16	2004-08-13	Pf Medicament	Microspheres effervescentes et leur procede de fabrication
US6534016B1 (en)	1997-04-30	2003-03-18	Richmond Cohen	Additive preparation and method of use thereof
US6225123B1 (en)	1997-04-30	2001-05-01	Becton Dickinson And Company	Additive preparation and method of use thereof
AU2002300487B2 (en) *	1997-04-30	2006-04-27	Becton, Dickinson And Company	Additive preparation and method of use thereof
CA2292628A1 (en) *	1997-06-11	1998-12-17	Janssen Pharmaceutica, N.V.	Immediate release ph-independent solid dosage form of (+)- or (-)-cisapride
SE9702533D0 (sv)	1997-07-01	1997-07-01	Astra Ab	New oral formulation
ATE241957T1 (de) *	1997-09-16	2003-06-15	Gergely Dr & Co	Brausezubereitung und verfahren zu ihrer herstellung
CA2305179A1 (en) *	1997-09-30	1999-04-08	Daiichi Pharmaceutical Co., Ltd.	Oral administration preparation
DE69817189T2 (de) *	1998-11-23	2004-06-17	E-Pharma Trento S.P.A., Trento Ravina	Verfahren zur Herstellung eines Brausegranulats
US6264984B1 (en)	1999-12-06	2001-07-24	Bristol-Myers Squibb Company	Effervescent histamine H2 antagonist composition
AU2003251152A1 (en) *	2002-07-03	2004-01-23	Shannon Biotechnology Ltd	Pharmaceutical formulations for preparing drink products
US7588696B2 (en)	2003-06-12	2009-09-15	Cargill, Incorporated	Antimicrobial water softener salt and solutions
US7090882B2 (en)	2003-06-12	2006-08-15	Cargill, Incorporated	Antimicrobial salt solutions for food safety applications
US7658959B2 (en)	2003-06-12	2010-02-09	Cargill, Incorporated	Antimicrobial salt solutions for food safety applications
US7883732B2 (en)	2003-06-12	2011-02-08	Cargill, Incorporated	Antimicrobial salt solutions for cheese processing applications
US8486472B2 (en)	2006-01-18	2013-07-16	Cargill, Incorporated	Antimicrobial salt solutions for food safety applications
AR060029A1 (es)	2006-03-02	2008-05-21	Unistraw Patent Holdings Ltd	Pajilla para beber adaptada para acondicionar progresivamente un ingrediente activo y metodo de fabricar dicha pajilla
BRPI0602825A2 (pt) *	2006-06-23	2012-04-24	Rhodia Br Ltda	formulação de pó efervescente auto-refrigerante para bebidas e uso de formulação em pó efervescente
WO2013043142A1 (en) *	2011-08-08	2013-03-28	Mahmut Bilgic	Production method for pharmaceutical formulations comprising an isoflavone
EP2788289B1 (de) *	2011-12-09	2019-07-31	Merck Patent GmbH	Porenarmes, wasserfreies natriumcarbonat
KR101591319B1 (ko) *	2013-12-03	2016-02-18	에프엔바이오 주식회사	홍삼 발포정의 제조방법
CN113975259B (zh) *	2021-09-14	2023-05-09	南京海纳医药科技股份有限公司	一种盐酸氨溴索复方泡腾片及其制备方法
CN114159399A (zh) *	2021-11-11	2022-03-11	大连双迪科技股份有限公司	一种口腔微泡含片及其制备方法

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
AU1039170A (en) *	1969-02-24	1971-07-22	Abbott Laboratories	Tableting medium
US4704269A (en) *	1985-06-11	1987-11-03	Hudson Pharmaceutical Corporation	Effervescent antacid and analgesic compositions
CA2023493C (en) *	1989-08-31	2000-01-04	Masami Moroi	Composition for foaming preparation
US5415870A (en) *	1991-07-01	1995-05-16	Gerhard Gergely	Effervescent systems using reaction doping agents

1994
- 1994-10-26 EP EP94203112A patent/EP0670160B1/de not_active Expired - Lifetime
- 1994-10-26 DK DK94203112T patent/DK0670160T3/da not_active Application Discontinuation
- 1994-10-26 ES ES94203112T patent/ES2136157T3/es not_active Expired - Lifetime
- 1994-10-26 AT AT94203112T patent/ATE182073T1/de active
- 1994-10-26 DE DE69419492T patent/DE69419492T2/de not_active Expired - Lifetime
1995
- 1995-02-23 KR KR1019960704598A patent/KR100358211B1/ko not_active Expired - Fee Related

Also Published As

Publication number	Publication date
DK0670160T3 (da)	2000-02-14
ES2136157T3 (es)	1999-11-16
DE69419492D1 (de)	1999-08-19
EP0670160B1 (de)	1999-07-14
EP0670160A1 (de)	1995-09-06
DE69419492T2 (de)	2000-02-03
KR100358211B1 (ko)	2003-02-06
KR970701038A (ko)	1997-03-17

Similar Documents

Publication	Publication Date	Title
DE69419492D1 (de)	1999-08-19	Ein Brausesystem und einen Arzneiwirkstoff enthaltendes granuläres Produkt bzw. Tablette sowie Verfahren zu deren Herstellung
CA2183952A1 (en)	1995-09-08	Granular product or tablet containing an effervescent system and an active pharmaceutical substance, as well as a method for its preparation
EP1452172A3 (de)	2004-11-03	Aus mehreren Einzeleinheiten zusammengesetztes pharmazeutisches Präparat.
DE3873410D1 (de)	1992-09-10	Formulierung zur oralen arzneistoffabgabe, sowie verfahren zu deren herstellung.
RU94046268A (ru)	1996-10-10	Микрогранулы омепразола и способ их получения
AU4113093A (en)	1993-11-29	Bioadhesive microspheres and their use as drug delivery and imaging systems
CA2213996A1 (en)	1997-07-17	Oral pharmaceutical dosage forms comprising a proton pump inhibitor and an antacid agent or alginate
WO2001003917A3 (de)	2001-05-03	Wirkstoffhaltigen mehrschichtfilm aus in situ vernetzten hydrophilen polymeren
CA2004598A1 (en)	1990-06-06	Medicinal aerosol formulations
CA2136848A1 (en)	1993-12-09	Pharmaceutically acceptable fixed-dried human blood platelets
CA2328234A1 (en)	1999-10-21	Compounds that inhibit the binding of integrins to their receptors
AU5267900A (en)	2000-11-21	Carboxylic acid derivatives that inhibit the binding of integrins to their receptors
HK27389A (en)	1989-04-07	Galenic compositions comprising calcitonin and their use
CA2009593A1 (en)	1990-08-09	Medicament containing dihydrolipoic acid as active substance
IE831313L (en)	1983-12-07	Stable pharmaceutical tablet.
FI872577A0 (fi)	1987-06-09	Menetelmä terapeuttisesti käyttökelpoisten, hydrofobisen tai niukkaliukoisen aineen mikronisoitujen, hydrofilisoitujen hiukkasten valmistamiseksi
CA2396223A1 (en)	2001-07-19	Instant granules and process for their formulation
ATE285754T1 (de)	2005-01-15	Pharmazeutische zusammensetzung mit lyophilisierten lyposomen welche einen unlöslichen aktiven wirkstoff einschliessen, verfahren zu dessen herstellung
IL146312A (en)	2010-12-30	3-(2-oxo-pyridinyl)-acylamino-propanoic acid derivatives that inhibit the binding of integrins to their receptors and pharmaceutical compositions comprising the same
ATE177944T1 (de)	1999-04-15	Pellets
CA2265788A1 (en)	1998-03-26	Thermoplastic polyurethanes containing active substances
AU4702093A (en)	1994-12-12	More easily biologically absorbed tablet containing dichloromethylene diphosphonic acid as the active agent
CA2000932A1 (en)	1990-04-26	Oral pharmaceutical controlled release multiple unit dosage form
IT8323058A0 (it)	1983-09-29	Derivati di 2,5-piperazindione biologicamente attivi, processi per la loro preparazione e composizioni farmaceutiche che licontengono.
ES2057021T3 (es)	1994-10-16	Un metodo de manufactura de una dosificacion farmaceutica solida en forma de triturado en tableta.